Effect_NN
of_IN
environmental_JJ
estrogens_NNS
on_IN
IL-1beta_NN
promoter_NN
activity_NN
in_IN
a_DT
macrophage_NN
cell_NN
line_NN
._.

Environmental_JJ
estrogens_NNS
or_CC
estrogen_NN
disrupters_NNS
have_VBP
recently_RB
received_VBN
a_DT
great_JJ
deal_NN
of_IN
attention_NN
because_NN
of_IN
their_PRP$
potential_JJ
health_NN
impact_NN
on_IN
reproductive_JJ
tissues_NNS
._.

Few_JJ
,_,
if_IN
any_DT
,_,
studies_NNS
have_VBP
been_VBN
made_VBN
on_IN
the_DT
impact_NN
of_IN
these_DT
compounds_NNS
on_IN
the_DT
immune_JJ
system_NN
._.

We_PRP
sought_VBD
to_TO
determine_VB
the_DT
activities_NNS
of_IN
various_JJ
environmental_JJ
estrogens_NNS
on_IN
the_DT
modulation_NN
of_IN
the_DT
interleukin-1beta_NN
-LRB-_-LRB-
IL-1beta_NN
-RRB-_-RRB-
gene_NN
in_IN
a_DT
model_NN
monocytic_JJ
cell_NN
line_NN
,_,
hER_NN
+_CC
IL-1beta-CAT_NN
+_NN
._.

This_DT
cell_NN
line_NN
stably_RB
transfected_VBN
with_IN
the_DT
human_JJ
estrogen_NN
receptor_NN
,_,
and_CC
an_DT
IL-1beta_NN
promoter_NN
construct_NN
fused_VBN
to_TO
the_DT
CAT_NN
reporter_NN
gene_NN
allows_VBZ
us_PRP
to_TO
monitor_VB
the_DT
effect_NN
of_IN
estrogenic_JJ
compounds_NNS
on_IN
IL-1beta_NN
promoter_NN
activity_NN
._.

17beta-estradiol_NN
-LRB-_-LRB-
E2_NN
-RRB-_-RRB-
markedly_RB
enhanced_VBD
lipopolysaccharide_NN
-_:
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
induced_VBN
IL-1beta_NN
promoter-driven_JJ
CAT_NN
activity_NN
in_IN
a_DT
dose-dependent_JJ
manner_NN
._.

The_DT
mycotoxins_JJ
alpha-zearalenol_NN
and_CC
zearalenone_NN
both_CC
exhibited_VBD
full_JJ
agonist_NN
activity_NN
,_,
but_CC
at_IN
lower_JJR
potencies_NNS
,_,
with_IN
EC50_NN
values_NNS
of_IN
1.8_CD
and_CC
54_CD
nM_NN
,_,
respectively_RB
,_,
compared_VBN
with_IN
E2_NN
at_IN
0.5_CD
nM_NN
._.

In_IN
addition_NN
,_,
genistein_NN
was_VBD
a_DT
very_RB
low-potency_JJ
agonist_NN
,_,
having_VBG
an_DT
EC50_NN
of_IN
1.5_CD
microM_NN
._.

Similar_JJ
to_TO
the_DT
E2_NN
response_NN
,_,
the_DT
slope_NN
factors_NNS
for_IN
alpha-zearalenol_NN
,_,
zearalenone_NN
,_,
and_CC
genistein_NN
were_VBD
close_JJ
to_TO
3.0_CD
,_,
suggesting_VBG
positive_JJ
cooperativity_NN
in_IN
the_DT
estrogenic_JJ
response_NN
._.

The_DT
activity_NN
of_IN
the_DT
mycotoxins_NNS
appeared_VBD
to_TO
be_VB
mediated_VBN
through_IN
the_DT
estrogen_NN
receptor_NN
,_,
since_IN
both_CC
the_DT
antiestrogens_JJ
H1285_NN
and_CC
ICI_NN
182_CD
,_,
780_CD
effectively_RB
inhibited_VBD
their_PRP$
agonist_NN
activity_NN
in_IN
a_DT
dose-dependent_JJ
manner_NN
._.

Representative_JJ
environmental_JJ
estrogenic_JJ
compounds_NNS
both_CC
from_IN
plant_JJ
and_CC
industrial_JJ
sources_NNS
were_VBD
also_RB
tested_VBN
._.

Unlike_IN
the_DT
mycoestrogens_NNS
,_,
none_NN
of_IN
the_DT
compounds_NNS
,_,
with_IN
the_DT
exception_NN
of_IN
genistein_NN
,_,
synergized_VBD
with_IN
LPS_NN
to_TO
enhance_VB
IL-1beta_NN
promoter_NN
activity_NN
._.

When_WRB
tested_VBN
for_IN
antiestrogenic_JJ
activity_NN
,_,
the_DT
industrial_JJ
compound_NN
4-octylphenol_NN
was_VBD
able_JJ
to_TO
antagonize_VB
the_DT
response_NN
to_TO
E2_NN
;_:
however_RB
,_,
the_DT
response_NN
was_VBD
three_CD
orders_NNS
of_IN
magnitude_NN
less_RBR
potent_JJ
than_IN
H_NN
1285_CD
._.

Naringenin_NN
,_,
a_DT
plant_NN
flavonoid_NN
,_,
showed_VBD
little_JJ
or_CC
no_DT
ability_NN
to_TO
antagonize_VB
the_DT
response_NN
to_TO
E2_NN
._.

Overall_RB
,_,
the_DT
results_NNS
show_VBP
that_IN
some_DT
environmental_JJ
estrogens_NNS
that_WDT
display_VBP
agonist_NN
activity_NN
in_IN
reproductive_JJ
tissue_NN
also_RB
have_VBP
an_DT
effect_NN
on_IN
IL-1_NN
gene_NN
expression_NN
in_IN
hemopoietic-derived_JJ
tissue_NN
._.

